Leigh Turner continues to question in the face of silence.
Kat Lanteigne argues that there are no good reasons for Canadians to be in the business of buying and selling blood.
Kirstin Borgerson explains why audiences presented with the facts in the Markingson case react with silence, and offers some thoughts on how bioethicists might break that silence.
Leigh Turner continues to call for an independent investigation of research practices at the University of Minnesota and the death of Dan Markingson.
Melissa Haussman suggests that Health Canada’s recent deliberations on the licensing of RU-486 are reminiscent of foot-dragging politics in the US.
Impact Ethics 